— Know what they know.
Not Investment Advice

OLK NASDAQ

Olink Holding AB (publ)
1W: +2.1% 1M: +6.7% 3M: +12.2% 1Y: +44.4% 3Y: -21.5%
$26.08
Last traded 2024-07-09 — delisted
NASDAQ · Healthcare · Medical - Diagnostics & Research · $3.2B mcap · 41M float · 1.35% daily turnover

Revenue Segmentation

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$170M +21.5% ▲
4Y CAGR: +42.1%
Gross Profit
$99M +4.6% ▲
4Y CAGR: +36.3%
Operating Income
-$50M -63.2% ▼
Net Income
-$32M -146.3% ▼
EPS (Diluted)
$-0.26 -136.4% ▼
EBITDA
-$31M -166.2% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
Revenue$42M$54M$95M$140M$170M
YoY Growth+0.0%+29.7%+75.7%+47.3%+21.5%
Cost of Revenue$13M$17M$37M$45M$71M
Gross Profit$29M$37M$58M$94M$99M
Gross Margin68.8%67.7%61.3%67.6%58.2%
R&D Expenses$5M$10M$22M$26M$31M
SG&A Expenses$35M$33M$81M$99M$118M
Operating Expenses$39M$42M$103M$125M$149M
Operating Income-$11M-$6M-$45M-$31M-$50M
Operating Margin-25.6%-11.3%-47.0%-21.9%-29.4%
Interest Expense$7M$7M$2M$531K$858K
Income Before Tax-$19M-$7M-$47M-$15M-$40M
Tax Expense-$652K-$479K-$8M-$3M-$8M
Net Income-$18M-$7M-$38M-$13M-$32M
Net Margin-42.9%-12.5%-40.4%-9.2%-18.6%
EPS (Diluted)$-0.15$-0.06$-0.39$-0.11$-0.26
EBITDA-$3M$6M-$30M$4M-$31M
Shares Outstanding119M119M99M119M124M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms